Produktname:3-amino-1-propan-2-ylpyrazole-4-carbonitrile
IUPAC Name:3-amino-1-(propan-2-yl)-1H-pyrazole-4-carbonitrile
- CAS:89897-29-0
- Molekulare Formel:C7H10N4
- Reinheit:95%+
- Katalognummer:CM336694
- Molekulargewicht:150.19
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:89897-29-0
- Molekulare Formel:C7H10N4
- Schmelzpunkt:-
- SMILES-Code:N#CC1=CN(C(C)C)N=C1N
- Dichte:
- Katalognummer:CM336694
- Molekulargewicht:150.19
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- Encorafenib plus Binimetinib
- U.S. FDA approved Pfizer's BRAFTOVI® (Encorafenib) + MEKTOVI® (Binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA's approval is based on data from the ongoing Phase 2 PHAROS clinical trial. Encorafenib is an oral small molecule BRAF kinase inhibitor, and Binimetinib is an oral small molecule MEK inhibitor targeting key proteins in the MAPK signaling pathway (RAS-RAF-MEK-ERK).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.